This news item from the Cornell Chronicle is about: Cornell researchers may have solved a 100-year puzzle: How to safely open and close the blood-brain barrier so that therapies to treat Alzheimer's disease, multiple sclerosis and cancers of the central nervous system might effectively be delivered. The researchers have identified that adenosine, a molecule produced by the body with many physiological functions including signaling trauma, can modulate the entry of large molecules into the brain. For the first time, the researchers discovered that when adenosine receptors are activated on cells that comprise the blood-brain barrier, a gateway into the blood-brain barrier can be established.
Cornell University, College of Veterinary Medicine
Cornell University. College of Veterinary Medicine -- Periodicals.; Bynoe, Margaret; Cornell Chronicle; Ramanujan, Krishna